Nrf2
The endogenous antioxidant master switch that activates >200 protective genes
Definition
Nrf2 (Nuclear factor erythroid 2-related factor 2) is a transcription factor that regulates the endogenous cellular antioxidant response. When activated by oxidative stress or specific activators, it translocates to the nucleus and binds ARE (Antioxidant Response Element) elements on DNA, activating transcription of more than 200 cytoprotective genes: antioxidant enzymes (glutathione peroxidase, superoxide dismutase, catalase), phase II detoxification enzymes, glutathione transporters, and repair proteins. It is the most powerful natural antioxidant defence mechanism in the body.
Detailed explanation
Nrf2 regulation: under basal conditions, it is retained in the cytoplasm bound to its inhibitor KEAP1, which directs it to ubiquitin-proteasome degradation. Upon oxidative or electrophilic stress, KEAP1 cysteine residues are modified, releasing Nrf2 to translocate to the nucleus.
Evidence-based natural activators: Sulforaphane (broccoli sprouts, Brassica oleracea): the most potent natural activator known. Therapeutic doses: 20-40 mg/day of glucoraphanin with mustard (which provides myrosinase) to activate sulforaphane. Jed Fahey's studies (Johns Hopkins) show robust Nrf2 activation in humans. Curcumin with piperine: moderate-high Nrf2 activation. Green tea EGCG: moderate activation. Ketones (β-hydroxybutyrate): in nutritional ketosis or fasting, indirectly activate Nrf2. Thermal hormesis: sauna at 80-100°C activates heat shock proteins and Nrf2. Exercise: controlled exercise-induced oxidative stress is the main physiological activator.
Strategic advantage vs exogenous antioxidants: rather than saturating the body with external antioxidants (which can even interfere with physiological ROS signalling of exercise), activating Nrf2 turns on the endogenous antioxidant machinery in a modulated and specific way. It is the preferred modern strategy in longevity medicine.
Chronic Nrf2 hyperactivation also has risks: facilitates survival of pre-existing tumour cells (several cancers hijack constitutive Nrf2). For this reason, pulsatile (cyclic, not continuous) activation is preferable.
Scientific sources
Interested in related treatments?
Generate My Protocol